In a move that could very well make users’ heart rates rise, an Indiana pharmaceuticals company has recalled a popular blood pressure medication for the fourth time. Torrent Pharmaceuticals has issued a recall for 36 additional lots of Losartan potassium tablets and 68 lots of Losartan Potassium/Hydrochlorothiazide tablets after traces of N-Methylnitrosobutyric acid, a cancer-causing carcinogen, were found in the medication. The FDA is warning patients who take the drug to contact their doctors before discontinuing the medication. Does it alarm you that a cancer-causing carcinogen can somehow slip into medicine? Should the FDA launch an investigation into the company before allowing them to distribute new pills?
Blood Pressure Medication Recalled for 4th Time
Comments are closed.